Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

Kloeckner R, Ruckes C, Kronfeld K, Wörns MA, Weinmann A, Galle PR, Lang H, Otto G, Eichhorn W, Schreckenberger M, Dueber C, Pitton MB.

Trials. 2014 Aug 6;15:311. doi: 10.1186/1745-6215-15-311.

2.

Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.

Kuhlmann JB, Euringer W, Spangenberg HC, Breidert M, Blum HE, Harder J, Fischer R.

Eur J Gastroenterol Hepatol. 2012 Apr;24(4):437-43. doi: 10.1097/MEG.0b013e3283502241.

PMID:
22261548
3.

Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.

Seidensticker R, Ricke J, Seidensticker M.

Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):319-32. doi: 10.1016/j.bpg.2015.02.009. Epub 2015 Feb 19. Review.

PMID:
25966431
4.

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.

Seinstra BA, Defreyne L, Lambert B, Lam MG, Verkooijen HM, van Erpecum KJ, van Hoek B, van Erkel AR, Coenraad MJ, Al Younis I, van Vlierberghe H, van den Bosch MA.

Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.

5.

Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy.

Schicho A, Pereira PL, Pützler M, Michalik K, Albrecht T, Nolte-Ernsting C, Stroszczynski C, Wiggermann P.

Med Sci Monit. 2017 Feb 13;23:796-800.

6.

Multi-disciplinary treatment for cholangiocellular carcinoma.

Shimoda M, Kubota K.

World J Gastroenterol. 2007 Mar 14;13(10):1500-4. Review.

7.

Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.

Herber S, Otto G, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann A, Thies J, Düber C, Pitton M.

Cardiovasc Intervent Radiol. 2007 Nov-Dec;30(6):1156-65. Epub 2007 May 17.

PMID:
17508242
8.

[A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].

Yakoshi Y, Toyoki Y, Ishido K, Kudo D, Kimura N, Wakiya T, Hakamada K.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1798-800. Japanese.

PMID:
24393926
9.

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC.

J Gastrointest Surg. 2008 Jan;12(1):129-37. Epub 2007 Sep 11.

PMID:
17851723
10.

Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment success.

Vogl TJ, Naguib NN, Nour-Eldin NE, Bechstein WO, Zeuzem S, Trojan J, Gruber-Rouh T.

Int J Cancer. 2012 Aug 1;131(3):733-40. doi: 10.1002/ijc.26407. Epub 2011 Oct 5.

11.

[Regional therapy of liver tumors].

Spangenberg HC, Mohr L, Blum HE.

Internist (Berl). 2007 Jan;48(1):40-5. German.

PMID:
17160664
12.

Nonsurgical therapies for hepatocellular and cholangiocellular carcinoma.

Schmassmann A.

Swiss Surg. 1999;5(3):116-21. Review.

PMID:
10414182
13.

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma.

Kolligs FT, Bilbao JI, Jakobs T, Iñarrairaegui M, Nagel JM, Rodriguez M, Haug A, D'Avola D, op den Winkel M, Martinez-Cuesta A, Trumm C, Benito A, Tatsch K, Zech CJ, Hoffmann RT, Sangro B.

Liver Int. 2015 Jun;35(6):1715-21. doi: 10.1111/liv.12750. Epub 2015 Jan 17.

PMID:
25443863
14.

Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.

Park SY, Kim JH, Yoon HJ, Lee IS, Yoon HK, Kim KP.

Clin Radiol. 2011 Apr;66(4):322-8. doi: 10.1016/j.crad.2010.11.002. Epub 2011 Jan 8.

PMID:
21356394
15.

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF.

J Vasc Interv Radiol. 2005 Mar;16(3):353-61.

PMID:
15758131
16.

Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver.

Kirchhoff T, Zender L, Merkesdal S, Frericks B, Malek N, Bleck J, Kubicka S, Baus S, Chavan A, Manns MP, Galanski M.

World J Gastroenterol. 2005 Feb 28;11(8):1091-5.

17.

Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.

Boehm LM, Jayakrishnan TT, Miura JT, Zacharias AJ, Johnston FM, Turaga KK, Gamblin TC.

J Surg Oncol. 2015 Feb;111(2):213-20. doi: 10.1002/jso.23781. Epub 2014 Sep 1. Review.

PMID:
25176325
18.

OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.

Poggi G, Amatu A, Montagna B, Quaretti P, Minoia C, Sottani C, Villani L, Tagliaferri B, Sottotetti F, Rossi O, Pozzi E, Zappoli F, Riccardi A, Bernardo G.

Cardiovasc Intervent Radiol. 2009 Nov;32(6):1187-92. doi: 10.1007/s00270-009-9694-4.

PMID:
19727937
19.

Locoregional therapy for cholangiocarcinoma.

Kuhlmann JB, Blum HE.

Curr Opin Gastroenterol. 2013 May;29(3):324-8. doi: 10.1097/MOG.0b013e32835d9dea. Review.

PMID:
23337933
20.

Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.

Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.

Liver Int. 2014 Jul;34(6):953-60. doi: 10.1111/liv.12364. Epub 2013 Nov 20.

PMID:
24134199

Supplemental Content

Support Center